 Brent Palmer
Concepts (452)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 37 | 2024 | 2836 | 3.630 |
Why?
| | CD4-Positive T-Lymphocytes | 34 | 2021 | 1091 | 3.360 |
Why?
| | Gastrointestinal Microbiome | 8 | 2024 | 697 | 1.870 |
Why?
| | Homosexuality, Male | 4 | 2022 | 184 | 1.500 |
Why?
| | Microbiota | 8 | 2024 | 762 | 1.470 |
Why?
| | HIV-1 | 17 | 2018 | 864 | 1.430 |
Why?
| | Sexual and Gender Minorities | 4 | 2022 | 214 | 1.360 |
Why?
| | HIV | 5 | 2019 | 234 | 1.300 |
Why?
| | Programmed Cell Death 1 Receptor | 11 | 2019 | 249 | 1.140 |
Why?
| | Inflammation | 9 | 2024 | 2837 | 1.030 |
Why?
| | Dysbiosis | 3 | 2021 | 181 | 0.960 |
Why?
| | Virus Replication | 5 | 2010 | 483 | 0.910 |
Why?
| | Epitopes, T-Lymphocyte | 6 | 2010 | 181 | 0.890 |
Why?
| | Receptors, CCR5 | 4 | 2021 | 56 | 0.880 |
Why?
| | Lymphocyte Activation | 16 | 2018 | 1142 | 0.870 |
Why?
| | CD8-Positive T-Lymphocytes | 16 | 2021 | 900 | 0.820 |
Why?
| | Feces | 4 | 2021 | 484 | 0.800 |
Why?
| | Berylliosis | 6 | 2013 | 186 | 0.760 |
Why?
| | Antigens, CD | 9 | 2020 | 521 | 0.750 |
Why?
| | Gastrointestinal Tract | 2 | 2014 | 195 | 0.720 |
Why?
| | Viral Load | 9 | 2020 | 466 | 0.720 |
Why?
| | Firmicutes | 1 | 2021 | 19 | 0.700 |
Why?
| | Macrophages, Alveolar | 3 | 2020 | 391 | 0.690 |
Why?
| | Antiretroviral Therapy, Highly Active | 7 | 2016 | 271 | 0.660 |
Why?
| | T-Lymphocytopenia, Idiopathic CD4-Positive | 1 | 2020 | 7 | 0.660 |
Why?
| | Anti-Inflammatory Agents | 3 | 2022 | 496 | 0.660 |
Why?
| | Up-Regulation | 9 | 2019 | 843 | 0.650 |
Why?
| | Germ-Free Life | 1 | 2019 | 34 | 0.620 |
Why?
| | Varicellovirus | 4 | 2022 | 17 | 0.610 |
Why?
| | Apoptosis Regulatory Proteins | 3 | 2008 | 188 | 0.590 |
Why?
| | Leukocytes, Mononuclear | 7 | 2022 | 558 | 0.590 |
Why?
| | T-Lymphocyte Subsets | 10 | 2016 | 417 | 0.550 |
Why?
| | CD57 Antigens | 3 | 2007 | 17 | 0.540 |
Why?
| | Anti-HIV Agents | 5 | 2016 | 778 | 0.530 |
Why?
| | Beryllium | 6 | 2009 | 153 | 0.520 |
Why?
| | B7-H1 Antigen | 6 | 2019 | 217 | 0.510 |
Why?
| | Interferon-gamma | 13 | 2013 | 789 | 0.500 |
Why?
| | Cytokines | 12 | 2021 | 2085 | 0.500 |
Why?
| | Lung | 16 | 2022 | 4060 | 0.480 |
Why?
| | Intestinal Mucosa | 1 | 2021 | 623 | 0.480 |
Why?
| | Cord Blood Stem Cell Transplantation | 1 | 2016 | 99 | 0.470 |
Why?
| | Humans | 85 | 2024 | 137585 | 0.460 |
Why?
| | Bacteria | 4 | 2022 | 858 | 0.460 |
Why?
| | Viremia | 5 | 2018 | 138 | 0.460 |
Why?
| | T-Lymphocytes, Regulatory | 7 | 2021 | 385 | 0.440 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2022 | 1242 | 0.440 |
Why?
| | Biota | 1 | 2013 | 34 | 0.420 |
Why?
| | B-Lymphocytes | 7 | 2022 | 847 | 0.400 |
Why?
| | Immunophenotyping | 9 | 2020 | 318 | 0.390 |
Why?
| | Bronchoalveolar Lavage Fluid | 9 | 2020 | 652 | 0.390 |
Why?
| | Herpesviridae Infections | 4 | 2019 | 147 | 0.390 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 9 | 2 | 2009 | 26 | 0.380 |
Why?
| | T-Lymphocytes | 9 | 2018 | 1996 | 0.370 |
Why?
| | Anti-Retroviral Agents | 4 | 2024 | 233 | 0.370 |
Why?
| | Down-Regulation | 2 | 2016 | 657 | 0.360 |
Why?
| | Herpes Zoster | 4 | 2022 | 316 | 0.350 |
Why?
| | Herpesvirus 3, Human | 4 | 2022 | 332 | 0.340 |
Why?
| | Interleukin-2 | 5 | 2013 | 455 | 0.340 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2019 | 549 | 0.340 |
Why?
| | Gene Products, gag | 3 | 2016 | 36 | 0.320 |
Why?
| | Receptors, OX40 | 1 | 2009 | 15 | 0.310 |
Why?
| | Adult | 29 | 2020 | 37929 | 0.310 |
Why?
| | Interleukin-10 | 4 | 2022 | 302 | 0.310 |
Why?
| | Antibodies, Viral | 4 | 2022 | 625 | 0.290 |
Why?
| | Virus Activation | 3 | 2019 | 88 | 0.290 |
Why?
| | Male | 34 | 2022 | 67762 | 0.290 |
Why?
| | Middle Aged | 25 | 2020 | 33479 | 0.280 |
Why?
| | Chronic Disease | 9 | 2014 | 1793 | 0.280 |
Why?
| | Immune System | 2 | 2019 | 177 | 0.280 |
Why?
| | Membrane Proteins | 3 | 2013 | 1164 | 0.280 |
Why?
| | Meningitis, Cryptococcal | 2 | 2020 | 30 | 0.270 |
Why?
| | Vitiligo | 2 | 2019 | 42 | 0.270 |
Why?
| | Dendritic Cells | 8 | 2019 | 483 | 0.270 |
Why?
| | Vaccination | 3 | 2021 | 1381 | 0.270 |
Why?
| | Immunologic Factors | 2 | 2022 | 236 | 0.270 |
Why?
| | Cerebrospinal Fluid | 2 | 2020 | 92 | 0.270 |
Why?
| | Interleukin-1 | 3 | 2019 | 965 | 0.270 |
Why?
| | Sexual Behavior | 3 | 2020 | 485 | 0.260 |
Why?
| | Mice | 18 | 2024 | 17787 | 0.250 |
Why?
| | Cohort Studies | 8 | 2019 | 5742 | 0.250 |
Why?
| | Female | 33 | 2023 | 73304 | 0.250 |
Why?
| | Animals | 26 | 2024 | 36940 | 0.250 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2010 | 718 | 0.250 |
Why?
| | Gene Expression | 1 | 2010 | 1502 | 0.240 |
Why?
| | DNA, Bacterial | 2 | 2019 | 337 | 0.230 |
Why?
| | Immunity, Innate | 3 | 2019 | 828 | 0.230 |
Why?
| | Host-Pathogen Interactions | 3 | 2024 | 364 | 0.230 |
Why?
| | Interleukin-12 | 2 | 2022 | 121 | 0.220 |
Why?
| | Fetomaternal Transfusion | 1 | 2023 | 11 | 0.210 |
Why?
| | Autoimmune Diseases | 2 | 2019 | 460 | 0.210 |
Why?
| | Cell Proliferation | 8 | 2010 | 2475 | 0.200 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2022 | 32 | 0.200 |
Why?
| | Disease Models, Animal | 7 | 2024 | 4295 | 0.200 |
Why?
| | Interleukin-6 | 3 | 2022 | 778 | 0.200 |
Why?
| | Young Adult | 9 | 2020 | 13209 | 0.190 |
Why?
| | Flow Cytometry | 9 | 2015 | 1178 | 0.190 |
Why?
| | Smokers | 2 | 2020 | 145 | 0.190 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2022 | 139 | 0.190 |
Why?
| | Peripheral Tolerance | 1 | 2022 | 15 | 0.190 |
Why?
| | HIV Core Protein p24 | 5 | 2010 | 31 | 0.190 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 152 | 0.190 |
Why?
| | Lymph Nodes | 3 | 2019 | 491 | 0.180 |
Why?
| | Monocytes | 4 | 2019 | 563 | 0.180 |
Why?
| | Exanthema | 1 | 2022 | 78 | 0.180 |
Why?
| | Killer Cells, Natural | 3 | 2014 | 449 | 0.180 |
Why?
| | Chickenpox | 1 | 2022 | 83 | 0.180 |
Why?
| | Graft vs Host Disease | 1 | 2023 | 252 | 0.180 |
Why?
| | Polysaccharides, Bacterial | 2 | 2022 | 70 | 0.170 |
Why?
| | Immunologic Memory | 6 | 2014 | 353 | 0.170 |
Why?
| | Immunity, Humoral | 1 | 2021 | 116 | 0.170 |
Why?
| | Macaca mulatta | 5 | 2022 | 166 | 0.170 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 4 | 2019 | 30 | 0.170 |
Why?
| | Lymphocyte Depletion | 3 | 2019 | 135 | 0.170 |
Why?
| | Lung Diseases | 3 | 2017 | 767 | 0.170 |
Why?
| | Melanoma, Experimental | 1 | 2021 | 114 | 0.170 |
Why?
| | Integrin alpha Chains | 1 | 2020 | 24 | 0.170 |
Why?
| | Pneumocystis | 2 | 1996 | 10 | 0.160 |
Why?
| | Cell Compartmentation | 1 | 2020 | 52 | 0.160 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2021 | 66 | 0.160 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 151 | 0.160 |
Why?
| | Haplotypes | 2 | 2019 | 494 | 0.160 |
Why?
| | Genome, Bacterial | 1 | 2021 | 142 | 0.160 |
Why?
| | Toll-Like Receptors | 2 | 2018 | 185 | 0.160 |
Why?
| | Fetal Blood | 2 | 2014 | 327 | 0.160 |
Why?
| | HLA-DR Antigens | 4 | 2016 | 228 | 0.150 |
Why?
| | Cells, Cultured | 9 | 2016 | 4193 | 0.150 |
Why?
| | Hexosaminidases | 1 | 2019 | 18 | 0.150 |
Why?
| | CD4 Lymphocyte Count | 4 | 2013 | 269 | 0.150 |
Why?
| | Audiovisual Aids | 1 | 2019 | 12 | 0.150 |
Why?
| | HLA-DQ Antigens | 2 | 2019 | 181 | 0.150 |
Why?
| | Prevotella | 1 | 2018 | 14 | 0.150 |
Why?
| | Genes, MHC Class II | 1 | 2019 | 74 | 0.150 |
Why?
| | Disease | 1 | 2019 | 98 | 0.150 |
Why?
| | Virus Latency | 1 | 2019 | 80 | 0.150 |
Why?
| | Pregnancy Complications | 1 | 2023 | 527 | 0.140 |
Why?
| | Emtricitabine | 2 | 2016 | 175 | 0.140 |
Why?
| | Monkey Diseases | 1 | 2018 | 20 | 0.140 |
Why?
| | Fluorescent Antibody Technique | 4 | 2015 | 390 | 0.140 |
Why?
| | Green Fluorescent Proteins | 2 | 2018 | 390 | 0.140 |
Why?
| | Colony Count, Microbial | 1 | 2018 | 120 | 0.140 |
Why?
| | Cytotoxicity, Immunologic | 2 | 2015 | 224 | 0.140 |
Why?
| | Tenofovir | 2 | 2016 | 243 | 0.140 |
Why?
| | Neoplasm Proteins | 1 | 2021 | 434 | 0.140 |
Why?
| | Open Reading Frames | 1 | 2018 | 123 | 0.140 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2018 | 95 | 0.140 |
Why?
| | Pneumonia, Pneumocystis | 2 | 1996 | 38 | 0.140 |
Why?
| | Principal Component Analysis | 1 | 2018 | 195 | 0.140 |
Why?
| | Colon | 1 | 2020 | 282 | 0.140 |
Why?
| | CTLA-4 Antigen | 2 | 2019 | 99 | 0.140 |
Why?
| | Aged | 11 | 2019 | 23961 | 0.130 |
Why?
| | In Vitro Techniques | 1 | 2019 | 1092 | 0.130 |
Why?
| | Multiple Myeloma | 1 | 2020 | 252 | 0.130 |
Why?
| | Case-Control Studies | 7 | 2020 | 3556 | 0.130 |
Why?
| | Vaccines, DNA | 1 | 2016 | 32 | 0.130 |
Why?
| | Genitalia | 1 | 2016 | 30 | 0.130 |
Why?
| | Skin | 2 | 2019 | 752 | 0.130 |
Why?
| | Immunization, Secondary | 1 | 2016 | 87 | 0.130 |
Why?
| | Melanoma | 3 | 2008 | 760 | 0.130 |
Why?
| | Antigen Presentation | 1 | 2017 | 218 | 0.130 |
Why?
| | Biopsy | 1 | 2020 | 1129 | 0.130 |
Why?
| | Withholding Treatment | 1 | 2016 | 76 | 0.120 |
Why?
| | Immune Tolerance | 2 | 2016 | 363 | 0.120 |
Why?
| | Mice, Knockout | 5 | 2021 | 3015 | 0.120 |
Why?
| | Histocompatibility Antigens Class II | 2 | 2016 | 367 | 0.120 |
Why?
| | Hepatitis C | 2 | 2009 | 271 | 0.120 |
Why?
| | Mouth | 1 | 2015 | 87 | 0.120 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 210 | 0.120 |
Why?
| | Retroviridae Infections | 1 | 2015 | 47 | 0.120 |
Why?
| | Cytomegalovirus Infections | 2 | 2015 | 192 | 0.120 |
Why?
| | Immune Evasion | 1 | 2015 | 58 | 0.120 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2016 | 203 | 0.120 |
Why?
| | Transplantation, Homologous | 1 | 2016 | 416 | 0.120 |
Why?
| | Rectum | 1 | 2016 | 185 | 0.120 |
Why?
| | Inflammation Mediators | 1 | 2018 | 513 | 0.110 |
Why?
| | Immune Reconstitution Inflammatory Syndrome | 1 | 2014 | 18 | 0.110 |
Why?
| | Survivors | 2 | 2016 | 493 | 0.110 |
Why?
| | Organophosphonates | 1 | 2015 | 93 | 0.110 |
Why?
| | Immunization | 2 | 2008 | 411 | 0.110 |
Why?
| | Software | 1 | 2019 | 665 | 0.110 |
Why?
| | Immunotherapy | 1 | 2019 | 641 | 0.110 |
Why?
| | Receptors, Interleukin-1 | 1 | 2015 | 216 | 0.110 |
Why?
| | Adolescent | 5 | 2020 | 21513 | 0.110 |
Why?
| | Deoxycytidine | 1 | 2015 | 179 | 0.110 |
Why?
| | Mortality | 1 | 2016 | 362 | 0.110 |
Why?
| | Macrophages | 4 | 2015 | 1547 | 0.110 |
Why?
| | Physical Fitness | 1 | 2015 | 209 | 0.110 |
Why?
| | Tropheryma | 1 | 2013 | 5 | 0.100 |
Why?
| | Whipple Disease | 1 | 2013 | 6 | 0.100 |
Why?
| | DNA, Ribosomal | 1 | 2013 | 88 | 0.100 |
Why?
| | Leukocyte Common Antigens | 3 | 2011 | 87 | 0.100 |
Why?
| | Biomarkers | 6 | 2019 | 4149 | 0.100 |
Why?
| | Adenine | 1 | 2015 | 271 | 0.100 |
Why?
| | Galectins | 1 | 2013 | 24 | 0.100 |
Why?
| | Mice, Inbred BALB C | 3 | 2012 | 1272 | 0.100 |
Why?
| | Smoking | 1 | 2020 | 1627 | 0.100 |
Why?
| | 4-1BB Ligand | 2 | 2009 | 7 | 0.100 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2015 | 213 | 0.100 |
Why?
| | Hematopoiesis | 2 | 2011 | 192 | 0.100 |
Why?
| | Cytomegalovirus | 3 | 2015 | 157 | 0.090 |
Why?
| | Interleukins | 1 | 2013 | 250 | 0.090 |
Why?
| | Neovascularization, Pathologic | 1 | 2013 | 301 | 0.090 |
Why?
| | Receptors, CXCR4 | 2 | 2010 | 86 | 0.090 |
Why?
| | Sequence Analysis, DNA | 2 | 2013 | 812 | 0.090 |
Why?
| | Interleukin Receptor Common gamma Subunit | 1 | 2011 | 14 | 0.090 |
Why?
| | RNA, Viral | 3 | 2004 | 656 | 0.090 |
Why?
| | Prognosis | 2 | 2017 | 4030 | 0.090 |
Why?
| | Th1 Cells | 2 | 2013 | 143 | 0.090 |
Why?
| | Cell Line | 5 | 2018 | 2847 | 0.090 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 1040 | 0.090 |
Why?
| | CCR5 Receptor Antagonists | 1 | 2010 | 6 | 0.080 |
Why?
| | Metagenome | 1 | 2011 | 147 | 0.080 |
Why?
| | Motor Activity | 1 | 2015 | 718 | 0.080 |
Why?
| | Lymphocyte Count | 4 | 2017 | 148 | 0.080 |
Why?
| | Forkhead Transcription Factors | 2 | 2010 | 191 | 0.080 |
Why?
| | Ecology | 1 | 2011 | 118 | 0.080 |
Why?
| | Ligands | 2 | 2014 | 664 | 0.080 |
Why?
| | Molecular Sequence Data | 2 | 2013 | 2900 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2426 | 0.080 |
Why?
| | Hydroxamic Acids | 1 | 2010 | 89 | 0.080 |
Why?
| | Skin Neoplasms | 2 | 2007 | 855 | 0.080 |
Why?
| | OX40 Ligand | 1 | 2009 | 10 | 0.080 |
Why?
| | T-Lymphocytes, Helper-Inducer | 2 | 2007 | 137 | 0.080 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2009 | 28 | 0.080 |
Why?
| | Cell Lineage | 1 | 2011 | 350 | 0.080 |
Why?
| | Vagina | 1 | 2011 | 187 | 0.080 |
Why?
| | Antibodies, Monoclonal | 5 | 2020 | 1430 | 0.080 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2009 | 87 | 0.080 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 1081 | 0.070 |
Why?
| | Risk Factors | 2 | 2020 | 10388 | 0.070 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2010 | 210 | 0.070 |
Why?
| | Myeloid Cells | 1 | 2009 | 148 | 0.070 |
Why?
| | Convalescence | 1 | 2007 | 17 | 0.070 |
Why?
| | Cell Division | 2 | 2013 | 794 | 0.070 |
Why?
| | Antibodies, Blocking | 1 | 2007 | 33 | 0.070 |
Why?
| | Genes, rev | 1 | 2007 | 2 | 0.070 |
Why?
| | Genes, tat | 1 | 2007 | 3 | 0.070 |
Why?
| | Homeodomain Proteins | 1 | 2011 | 506 | 0.070 |
Why?
| | Gene Expression Regulation | 4 | 2019 | 2607 | 0.070 |
Why?
| | Arthritis, Experimental | 1 | 2009 | 147 | 0.070 |
Why?
| | Tumor Escape | 1 | 2007 | 42 | 0.070 |
Why?
| | Cystatins | 1 | 2006 | 7 | 0.070 |
Why?
| | Bronchoalveolar Lavage | 1 | 2007 | 93 | 0.070 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2006 | 101 | 0.060 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2007 | 97 | 0.060 |
Why?
| | RNA, Catalytic | 1 | 2007 | 187 | 0.060 |
Why?
| | Analysis of Variance | 1 | 2009 | 1316 | 0.060 |
Why?
| | Interleukin-1beta | 2 | 2021 | 372 | 0.060 |
Why?
| | Receptors, CCR7 | 1 | 2005 | 32 | 0.060 |
Why?
| | Ecosystem | 1 | 2011 | 596 | 0.060 |
Why?
| | Receptors, Chemokine | 1 | 2005 | 47 | 0.060 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2005 | 50 | 0.060 |
Why?
| | Prospective Studies | 4 | 2016 | 7604 | 0.060 |
Why?
| | Hematopoietic Stem Cell Transplantation | 3 | 2023 | 622 | 0.060 |
Why?
| | Signal Transduction | 4 | 2021 | 5079 | 0.060 |
Why?
| | Hepacivirus | 1 | 2007 | 261 | 0.060 |
Why?
| | Hepatitis C, Chronic | 1 | 2007 | 164 | 0.060 |
Why?
| | Programmed Cell Death 1 Ligand 2 Protein | 2 | 2019 | 15 | 0.060 |
Why?
| | RNA, Small Interfering | 1 | 2007 | 622 | 0.060 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2015 | 346 | 0.060 |
Why?
| | Antigens, CD34 | 3 | 2011 | 88 | 0.050 |
Why?
| | Lung Neoplasms | 1 | 2017 | 2526 | 0.050 |
Why?
| | United States | 1 | 2021 | 14841 | 0.050 |
Why?
| | Zimbabwe | 1 | 2024 | 58 | 0.050 |
Why?
| | Neoplasms | 1 | 2019 | 2671 | 0.050 |
Why?
| | Lipopolysaccharides | 2 | 2019 | 886 | 0.050 |
Why?
| | DNA-Binding Proteins | 2 | 2011 | 1502 | 0.050 |
Why?
| | Mice, Inbred C57BL | 4 | 2019 | 5757 | 0.050 |
Why?
| | Immunoglobulin Isotypes | 1 | 2022 | 34 | 0.050 |
Why?
| | Immunoglobulin D | 1 | 2022 | 30 | 0.050 |
Why?
| | Pulmonary Fibrosis | 1 | 2006 | 402 | 0.050 |
Why?
| | CD4 Antigens | 3 | 2007 | 141 | 0.050 |
Why?
| | Bacteroides fragilis | 1 | 2022 | 13 | 0.050 |
Why?
| | Cell Differentiation | 2 | 2015 | 1991 | 0.050 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 1 | 2002 | 98 | 0.050 |
Why?
| | Lectins, C-Type | 1 | 2002 | 67 | 0.050 |
Why?
| | Hypersensitivity | 1 | 2005 | 257 | 0.050 |
Why?
| | Allergens | 1 | 2005 | 409 | 0.050 |
Why?
| | Cell Count | 2 | 2016 | 324 | 0.050 |
Why?
| | Mice, SCID | 2 | 2007 | 367 | 0.050 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2002 | 230 | 0.040 |
Why?
| | CD28 Antigens | 2 | 2013 | 53 | 0.040 |
Why?
| | Longitudinal Studies | 3 | 2018 | 2844 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 2 | 2003 | 336 | 0.040 |
Why?
| | Interferons | 1 | 2022 | 202 | 0.040 |
Why?
| | Vaccines, Synthetic | 1 | 2021 | 126 | 0.040 |
Why?
| | Transforming Growth Factor beta | 3 | 2008 | 480 | 0.040 |
Why?
| | Species Specificity | 2 | 2016 | 585 | 0.040 |
Why?
| | Immunity | 1 | 2021 | 143 | 0.040 |
Why?
| | Proteasome Inhibitors | 1 | 2020 | 46 | 0.040 |
Why?
| | Phenotype | 3 | 2019 | 3196 | 0.040 |
Why?
| | Mice, Transgenic | 2 | 2019 | 2167 | 0.040 |
Why?
| | Arthritis, Rheumatoid | 1 | 2009 | 1167 | 0.040 |
Why?
| | Bacteroides | 1 | 2019 | 21 | 0.040 |
Why?
| | B7-2 Antigen | 2 | 2013 | 27 | 0.040 |
Why?
| | Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1999 | 27 | 0.040 |
Why?
| | Genes, T-Cell Receptor beta | 1 | 1999 | 22 | 0.040 |
Why?
| | Ganglia | 1 | 2019 | 18 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2015 | 1738 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2019 | 2833 | 0.040 |
Why?
| | HLA-DQ beta-Chains | 1 | 2019 | 63 | 0.040 |
Why?
| | Macrophages, Peritoneal | 1 | 2019 | 94 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2019 | 7635 | 0.040 |
Why?
| | Fetus | 1 | 2023 | 806 | 0.040 |
Why?
| | Spondylarthritis | 1 | 2019 | 50 | 0.040 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 2 | 2010 | 81 | 0.040 |
Why?
| | Survival Rate | 2 | 2017 | 1972 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2019 | 121 | 0.040 |
Why?
| | Coinfection | 1 | 2020 | 137 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2019 | 239 | 0.040 |
Why?
| | Genetic Loci | 1 | 2019 | 288 | 0.030 |
Why?
| | Protein Transport | 1 | 2019 | 445 | 0.030 |
Why?
| | Antigen-Presenting Cells | 1 | 2017 | 156 | 0.030 |
Why?
| | Cell Communication | 1 | 2018 | 315 | 0.030 |
Why?
| | Virus Diseases | 1 | 2019 | 212 | 0.030 |
Why?
| | Adventitia | 1 | 2016 | 40 | 0.030 |
Why?
| | Sheep | 1 | 1999 | 856 | 0.030 |
Why?
| | Membrane Glycoproteins | 2 | 2013 | 500 | 0.030 |
Why?
| | Morbidity | 1 | 2017 | 324 | 0.030 |
Why?
| | Life Style | 1 | 2018 | 490 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 313 | 0.030 |
Why?
| | Spermatozoa | 1 | 2016 | 94 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2019 | 620 | 0.030 |
Why?
| | Virulence | 1 | 1996 | 267 | 0.030 |
Why?
| | Vero Cells | 1 | 2015 | 69 | 0.030 |
Why?
| | Neuroglia | 1 | 2016 | 173 | 0.030 |
Why?
| | Retroviridae | 1 | 2015 | 97 | 0.030 |
Why?
| | Viral Proteins | 1 | 2018 | 342 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 852 | 0.030 |
Why?
| | HIV Antigens | 1 | 2015 | 18 | 0.030 |
Why?
| | Immobilized Proteins | 1 | 2015 | 10 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2019 | 6079 | 0.030 |
Why?
| | Neutralization Tests | 1 | 2015 | 75 | 0.030 |
Why?
| | Blood Cells | 1 | 2014 | 40 | 0.030 |
Why?
| | NF-kappa B | 1 | 2019 | 691 | 0.030 |
Why?
| | Mice, Nude | 1 | 1996 | 698 | 0.030 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2019 | 351 | 0.030 |
Why?
| | Autoantibodies | 1 | 2022 | 1496 | 0.030 |
Why?
| | Safety | 1 | 2016 | 338 | 0.030 |
Why?
| | Lymphocyte Subsets | 1 | 2014 | 87 | 0.030 |
Why?
| | Extracellular Space | 1 | 2015 | 119 | 0.030 |
Why?
| | Enhancer Elements, Genetic | 1 | 2016 | 190 | 0.030 |
Why?
| | Endotoxemia | 1 | 2015 | 86 | 0.030 |
Why?
| | Endostatins | 1 | 2013 | 10 | 0.030 |
Why?
| | Activins | 1 | 2013 | 28 | 0.030 |
Why?
| | Integrin alphaVbeta3 | 1 | 2013 | 18 | 0.030 |
Why?
| | Global Health | 1 | 2017 | 386 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 283 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2020 | 1079 | 0.030 |
Why?
| | Genotype | 1 | 2019 | 1916 | 0.030 |
Why?
| | Colitis | 1 | 2016 | 266 | 0.030 |
Why?
| | Nitrogen Oxides | 1 | 2013 | 55 | 0.030 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2013 | 108 | 0.030 |
Why?
| | B7-1 Antigen | 1 | 2013 | 58 | 0.030 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2013 | 132 | 0.030 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2013 | 38 | 0.030 |
Why?
| | Recurrence | 1 | 2016 | 1060 | 0.030 |
Why?
| | Lymphokines | 1 | 2013 | 131 | 0.030 |
Why?
| | DNA, Viral | 1 | 2015 | 364 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2017 | 674 | 0.030 |
Why?
| | Muromegalovirus | 1 | 2013 | 23 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 810 | 0.030 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2013 | 107 | 0.030 |
Why?
| | Models, Immunological | 1 | 2013 | 100 | 0.030 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2013 | 198 | 0.030 |
Why?
| | Prednisone | 1 | 2014 | 240 | 0.030 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2013 | 165 | 0.020 |
Why?
| | Receptors, Virus | 1 | 2013 | 83 | 0.020 |
Why?
| | Interleukin-8 | 1 | 2013 | 268 | 0.020 |
Why?
| | Interleukin-15 | 1 | 2013 | 98 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 861 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1353 | 0.020 |
Why?
| | Fibroblasts | 1 | 2016 | 996 | 0.020 |
Why?
| | Peritoneum | 1 | 2011 | 44 | 0.020 |
Why?
| | Severity of Illness Index | 2 | 2010 | 2828 | 0.020 |
Why?
| | Lymphoid Tissue | 1 | 2011 | 75 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2015 | 893 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2013 | 545 | 0.020 |
Why?
| | Smad3 Protein | 1 | 2010 | 43 | 0.020 |
Why?
| | Immunoglobulins | 1 | 2011 | 171 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 6763 | 0.020 |
Why?
| | Mucous Membrane | 1 | 2011 | 125 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2017 | 1317 | 0.020 |
Why?
| | Valproic Acid | 1 | 2010 | 48 | 0.020 |
Why?
| | Glioblastoma | 1 | 2013 | 345 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2016 | 1096 | 0.020 |
Why?
| | Antibody Formation | 1 | 2011 | 298 | 0.020 |
Why?
| | CD3 Complex | 1 | 2010 | 106 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2010 | 327 | 0.020 |
Why?
| | Glucocorticoids | 1 | 2014 | 594 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2011 | 347 | 0.020 |
Why?
| | Radiation Chimera | 1 | 2009 | 29 | 0.020 |
Why?
| | Radiation Injuries, Experimental | 1 | 2009 | 22 | 0.020 |
Why?
| | Immunosuppressive Agents | 1 | 2014 | 890 | 0.020 |
Why?
| | Mice, Inbred DBA | 1 | 2009 | 200 | 0.020 |
Why?
| | Glucocorticoid-Induced TNFR-Related Protein | 1 | 2008 | 5 | 0.020 |
Why?
| | Bone Resorption | 1 | 2009 | 86 | 0.020 |
Why?
| | Liver | 2 | 2007 | 1943 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2016 | 2189 | 0.020 |
Why?
| | Remission, Spontaneous | 1 | 2007 | 40 | 0.020 |
Why?
| | Research | 1 | 2011 | 451 | 0.020 |
Why?
| | Alleles | 2 | 2003 | 891 | 0.020 |
Why?
| | Toll-Like Receptor 2 | 1 | 2008 | 115 | 0.020 |
Why?
| | Mutation | 1 | 2019 | 3958 | 0.020 |
Why?
| | Interleukin-3 Receptor alpha Subunit | 1 | 2007 | 17 | 0.020 |
Why?
| | Bone Marrow Transplantation | 1 | 2009 | 286 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2019 | 2129 | 0.020 |
Why?
| | Culture Media, Conditioned | 1 | 2007 | 110 | 0.020 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 226 | 0.020 |
Why?
| | Precision Medicine | 1 | 2011 | 429 | 0.020 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2007 | 173 | 0.020 |
Why?
| | Transplantation Chimera | 1 | 2007 | 54 | 0.020 |
Why?
| | Blood | 1 | 2007 | 107 | 0.020 |
Why?
| | Cystatin C | 1 | 2006 | 65 | 0.020 |
Why?
| | CD8 Antigens | 1 | 2006 | 75 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2007 | 216 | 0.020 |
Why?
| | Fibrosis | 1 | 2009 | 552 | 0.020 |
Why?
| | Transplantation, Heterologous | 1 | 2006 | 194 | 0.020 |
Why?
| | Bacillus subtilis | 1 | 2006 | 66 | 0.020 |
Why?
| | Toll-Like Receptor 4 | 1 | 2008 | 273 | 0.020 |
Why?
| | Gene Silencing | 1 | 2007 | 195 | 0.020 |
Why?
| | Thymus Gland | 1 | 2007 | 312 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 5778 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2007 | 319 | 0.020 |
Why?
| | Time Factors | 1 | 2016 | 6828 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2007 | 382 | 0.010 |
Why?
| | Immunity, Cellular | 1 | 2007 | 268 | 0.010 |
Why?
| | Infant | 1 | 2019 | 9465 | 0.010 |
Why?
| | Brain | 1 | 2016 | 2668 | 0.010 |
Why?
| | Apoptosis | 1 | 2013 | 2553 | 0.010 |
Why?
| | Child, Preschool | 1 | 2019 | 11074 | 0.010 |
Why?
| | Aging | 1 | 2014 | 1864 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 2007 | 1389 | 0.010 |
Why?
| | Clone Cells | 1 | 2003 | 265 | 0.010 |
Why?
| | HLA-DRB1 Chains | 1 | 2003 | 112 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2003 | 239 | 0.010 |
Why?
| | Hypertension, Pulmonary | 1 | 2013 | 1910 | 0.010 |
Why?
| | CD40 Antigens | 1 | 2002 | 89 | 0.010 |
Why?
| | Consensus Sequence | 1 | 1999 | 73 | 0.010 |
Why?
| | Child | 1 | 2019 | 21935 | 0.010 |
Why?
| | Germ Cells | 1 | 1999 | 64 | 0.010 |
Why?
| | DNA, Complementary | 1 | 1999 | 272 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1999 | 343 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1999 | 385 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1999 | 534 | 0.010 |
Why?
| | Disease Progression | 1 | 2005 | 2757 | 0.010 |
Why?
| | Opportunistic Infections | 1 | 1996 | 46 | 0.010 |
Why?
| | Protein Binding | 1 | 2003 | 2224 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1999 | 1062 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 1999 | 660 | 0.010 |
Why?
| | Base Sequence | 1 | 1999 | 2181 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1999 | 2139 | 0.010 |
Why?
| | Genetic Variation | 1 | 1999 | 991 | 0.010 |
Why?
|
|
Palmer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|